Lindbrook Capital’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $13.6K | Buy |
2,036
+1,385
| +213% | +$9.24K | ﹤0.01% | 1526 |
|
|
2024
Q4 | $8.18K | Buy |
651
+537
| +471% | +$6.75K | ﹤0.01% | 1756 |
|
|
2024
Q3 | $2.11K | Sell |
114
-103
| -47% | -$1.9K | ﹤0.01% | 2324 |
|
|
2024
Q2 | $4.67K | Buy |
217
+43
| +25% | +$926 | ﹤0.01% | 2029 |
|
|
2024
Q1 | $4.69K | Buy |
174
+5
| +3% | +$135 | ﹤0.01% | 1922 |
|
|
2023
Q4 | $5.07K | Sell |
169
-14
| -8% | -$420 | ﹤0.01% | 1881 |
|
|
2023
Q3 | $3.75K | Buy |
183
+95
| +108% | +$1.95K | ﹤0.01% | 1898 |
|
|
2023
Q2 | $1.75K | Hold |
88
| – | – | ﹤0.01% | 2202 |
|
|
2023
Q1 | $1.51K | Hold |
88
| – | – | ﹤0.01% | 2351 |
|
|
2022
Q4 | $1.72K | Hold |
88
| – | – | ﹤0.01% | 2296 |
|
|
2022
Q3 | $1K | Hold |
88
| – | – | ﹤0.01% | 2462 |
|
|
2022
Q2 | $1K | Buy |
+88
| New | +$1K | ﹤0.01% | 2342 |
|
|
2021
Q2 | – | Sell |
-236
| Closed | -$10K | – | 1995 |
|
|
2021
Q1 | $10K | Sell |
236
-1,364
| -85% | -$57.8K | ﹤0.01% | 1024 |
|
|
2020
Q4 | $88K | Sell |
1,600
-100
| -6% | -$5.5K | 0.02% | 264 |
|
|
2020
Q3 | $39K | Buy |
+1,700
| New | +$39K | 0.01% | 420 |
|
|
2020
Q2 | – | Sell |
-1,500
| Closed | -$21K | – | 1872 |
|
|
2020
Q1 | $21K | Hold |
1,500
| – | – | 0.01% | 527 |
|
|
2019
Q4 | $34K | Sell |
1,500
-1,500
| -50% | -$34K | 0.01% | 560 |
|
|
2019
Q3 | $35K | Buy |
3,000
+2,000
| +200% | +$23.3K | 0.01% | 529 |
|
|
2019
Q2 | $15K | Buy |
+1,000
| New | +$15K | 0.01% | 784 |
|
|
2019
Q1 | – | Sell |
-500
| Closed | -$7K | – | 1490 |
|
|
2018
Q4 | $7K | Buy |
+500
| New | +$7K | ﹤0.01% | 922 |
|